ZEUCF yields 52631.58% · MRK yields 2.76%● Live data
📍 ZEUCF pulled ahead of the other in Year 1
Combined, ZEUCF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ZEUCF + MRK for your $10,000?
ZeU Technologies Inc. engages in the block-chain technology development business. The company offers distributed ledger technology (DLT)-based secure email system, which authenticates the sender and the recipient, encrypts the data, and stores it on the distributed storage service; random numbers generation technology to create actual random numbers; cross-chain transactions technology; transactional decentralized communication protocol infrastructure, a system that removes the smart contract layer; distributed data real-time backup and recovery, a system for realizing real-time data backup and recovery based on DLT; converting database applications into DLT applications; biocrypt digital wallet technology, a biometric digital wallet for the cold storage of cryptocurrencies; augmenting database applications technology with DLT; and symmetric asynchronous generative encryption technology for security of data. It also provides Mula platform, a modular platform that anonymizes and protects a user's online information; MulaMail, an enterprise solution; safe custody of private data using blockchain technology; and permission-based multi-level encryption scheme document for decentralized storage. In addition, the company offers virtual identity and user management infrastructure; ZeU Gaming platform; and ZeUPay for custodial and legacy banking support for the Mula platform, as well as operates mula.education, which allows users to practice the encryption methods used in the Mula platform. The company was formerly known as ZeU Crypto Networks Inc. and changed its name to ZeU Technologies Inc. in October 15, 2020. ZeU Technologies Inc. was incorporated in 2018 and is headquartered in Montreal, Canada.
Full ZEUCF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.